Fate Therapeutics Inc (FATE)

2.88
0.14 4.64
NASDAQ : Health Care
Prev Close 3.02
Open 2.99
Day Low/High 2.85 / 2.99
52 Wk Low/High 1.46 / 8.05
Volume 186.07K
Avg Volume 265.50K
Exchange NASDAQ
Shares Outstanding 41.42M
Market Cap 130.05M
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Fate Therapeutics To Kick-Off 2017 Annual Meeting Of International Society For Stem Cell Research With Off-the-Shelf Natural Killer Cell Cancer Immunotherapy Focus Session

New Preclinical Data to be Presented on First-of-Kind Product Candidates Derived from Master Engineered Pluripotent Cell Lines

The Setup Is Good for a Bounce, but it Hasn't Happened Yet

The Setup Is Good for a Bounce, but it Hasn't Happened Yet

Some small names are interesting, but more-aggressive position trades are not developing right now.

3 Small Biotechs With Insider Buying

3 Small Biotechs With Insider Buying

Insiders have an edge in this complex sector, so it's worth checking them out.

On the Hunt for Holiday Movers

On the Hunt for Holiday Movers

I'm still bullish, but I'm looking over my shoulder to see if there are some bears sneaking up.

Rotation Is the Name of the Game

Rotation Is the Name of the Game

Traders are also looking for smaller-caps that can move big around the holiday.

Shark Bites: These Steel Names Are Looking Strong

Shark Bites: These Steel Names Are Looking Strong

A few plays on this holiday trading.

Fate Therapeutics Announces Oral Presentation On Natural Killer Cell Product Candidate FATE-NK100 At The 2016 ASH Annual Meeting

Fate Therapeutics Announces Oral Presentation On Natural Killer Cell Product Candidate FATE-NK100 At The 2016 ASH Annual Meeting

Five Additional Presentations to Highlight the Company's Cellular Immunotherapy Programs